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Dopaminergic Neurons in the Ventral Tegmental Area
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1

Department of Biology, University of Puerto Rico, Río Piedras; 2Department of Physiology, Universidad Central del
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Abstract: Chronic cocaine administration leads to catecholamine reuptake inhibition which enhances reward and motivational behaviors. Ventral Tegmental Area dopaminergic (VTA DA) neuronal firing is associated with changes in reward
predictive signals. Acute cocaine injections inhibit putative VTA DA cell firing in vertebrates. Parthenolide, a compound
isolated from the feverfew plant (Tanacetum parthenium), has been shown to substantially inhibit cocaine’s locomotion
effects in a planarian animal model (Pagán et al., 2008). Here we investigated the effects of parthenolide on the spontaneous firing activity of putative VTA DA neurons in anesthetized male rats (250-300g). Single-unit recordings were
analyzed after intravenous (i.v.) parthenolide administration followed by 1mg/kg i.v. cocaine injection. Results showed
that parthenolide at 0.125 mg/kg and 0.250mg/kg significantly blocked cocaine’s inhibitory effect on DA neuronal firing
rate and bursting activity (p< 0.05, two way ANOVA). We propose that parthenolide might inhibit cocaine’s effects
on VTA DA neurons via its interaction with a common binding site at monoamine transporters. It is suggested that
parthenolide could have a potential use as an overdose antidote or therapeutic agent to cocaine intoxication.
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INTRODUCTION
The mesocorticolimbic circuit functions as the center for
reward and motivation [1]. The Ventral Tegmental Area
(VTA) forms part of this circuit, and is identified with modulating want and motivation [2]. VTA dopaminergic neuronal
firing is associated with changes in reward predictive signals
[3]. During chronic cocaine abuse, catecholamine reuptake
mechanisms are inhibited, causing an increase in neurotransmitters at the synapse [4]. This increased concentration
of dopamine, serotonin, or norepinephrine can have lasting
effects in the form of neuroadaptations, such as enhanced
reward and motivational behaviors, and serious short term
effects such as cardiac arrest in susceptible individuals.
The purpose of this study was to characterize the effect of
the drug known as parthenolide, a compound isolated from
the feverfew plant (Tanacetum parthenium), on the rat animal model. Studies have shown that parthenolide has potent
anti-inflammatory effects, but recent evidence suggests a
potential blockade action on cocaine’s effects in an invertebrate animal model [5, 6]. Behavioral evidence in planarians
supports that parthenolide can bind to catecholamine
reuptake transporters without impairing function, and this
binding prevents cocaine’s effect by allosteric competition
[4].
Dopamine (DA) cells in the VTA have an important role
in pleasure-seeking behavior modulation [7]. They are also
innervated by noradrenergic afferents and are thus modulated
in part by norepinephrine [8]. Acute cocaine administration
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can be observed by the inhibition of VTA DA cell activity
[9]. Thus, we tested parthenolide’s effect on the inhibition
produced by cocaine in the rat VTA DA cells when both are
injected intravenously.
MATERIALS AND METHODS
Animal Preparation
Sprague-Dawley male rats (250-–300 g) were used as the
experimental subjects for all of these studies. The animals
were housed two per cage in the colony room and maintained at a constant temperature and humidity with a 12-hr
hour light/dark cycle. They were randomly assigned to the
groups before the study begins. All efforts were made to
minimize animal discomfort and to limit the number of animals used in this project. The procedures were approved by
the Universidad Central del Caribe Institutional Animal Care
and Use Committee.
Animals were anesthetized with chloral hydrate (400
mg/kg, i.p.). Afterwards the animal was placed in the stereotaxic apparatus for electrophysiological recordings. Rats
were secured in a stereotaxic apparatus in the flat skull position [6]. Body temperature was maintained (37 °C) with a
thermostatically controlled heating pad. A craniotomy was
performed and electrodes were lowered into the VTA.
Stereotaxic coordinates for the ventral tegmental area (VTA)
were 3.0 to 3.4 mm anterior to lambda, 0.4 to 1.0 mm
medial/lateral, and 6.0 to 8.0 mm dorsal/ventral from the
cortical surface.
Drugs were administered intravenously via a jugular
catheter. Parthenolide (Tocris) was diluted with 20%
DMSO/80% dH2O until a concentrations of 0.125 mg/kg or
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Fig. (1). Effects of parthenolide on VTADA neuronal firing rate. Parthenolide administration (0.125 mg/kg, i.v. or 0.250 mg/kg, i.v.) blocked
cocaine’s (1 mg/kg, i.v.) inhibitory actions on VTADA firing activity. (Two way ANOVA, P<0.0001).

0.250mg/kg were achieved. Cocaine was used in a dose of
1mg/kg.
Extracellular Recording
Single-barrel microelectrodes filled with Pontamine Sky
Blue Solution 2% (PSB), tip diameter 3-6 micrometers, were
used to record single unit activity in the VTA. The recording
microelectrode was slowly advanced 7-8 mm until single
unit activity correspondent of waveform parameters for a
dopaminergic cell were observed (characteristically low (4-5
spikes/sec) firing rate, large action potential amplitude, and
1.1ms wavelength from peak to negative trough). Neuronal
activity was amplified (DAM 80 amplifier, World Precision
Instruments) and sent to an interface for digitalization. The
interface’s output was fed to a computer for on-line waveform display (Spike 2, Cambridge Electronic Design, UK).
Histological Verification of Recording Sites
The last recording site in an experiment was marked by
iontophoresis of pontamine sky blue (2%, -7 A for 10 min-

utes). The animal was euthanized, the brain removed and put
in 8% formaline and stored in a refrigerator. The location of
the electrodes was determined during microscopic examination of Nissl-stained, coronal brain sections, cut at 40- to 50micron intervals in a cryostat.
Data Analysis
Data was analyzed using Spike2 bundled software with
Principal Component Analysis (PCA) for spike isolation and
data mining. Microsoft Excel and GraphPad Prism 4.5 software were used for statistical analysis. Two way repeated
measures ANOVA with a Bonferroni post hoc test were employed.
RESULTS
Fig. (1) shows the effects of cocaine and parthenolide
administration on VTA DA firing rate. Intravenous cocaine
injections induced an inhibition in firing activity that peak
approximately 9-12 minutes after the injection. Parthenolide,
(0.125 mg/kg or 0.250 mg/kg intravenously), was adminis-
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Fig. (2). Distribution of bursting events in time as percent of the total bursting activity. Cocaine administration almost totally inhibited bursting activity of VTADA cells. Most part of cocaine’s bursting events occurred before cocaine administration. Animals previously injected
with parthenolide maintained a relatively homogeneous distribution of bursting activity. There was a significant difference in bursting activity between cocaine and parthenolide treated groups (Two way ANOVA, P<0.0001).

tered before a single cocaine (1mg/kg,i.v.) injection. The
results showed that cocaine’s inhibitory action was not affected when animals were pre-injected with saline. On the
other hand, cocaine’s inhibitory action was blocked when
rats were pre-injected by either dose of parthenolide,
(0.125mg/kg or 0.250 mg/kg). These results were determined
highly significant by a repeated measures two-way ANOVA
[F(18,189)  4.05, p < 0.0001].
When doses were compared, parthenolide at 0.125
mg/kg, seems to be more effective at inhibiting cocaine’s
action, although the difference between 0.250 mg/kg and
0.125 mg/kg was not statistically significant.
Bursting analysis was conducted to investigate whether
acute cocaine injections induced changes in the firing pattern
of VTA DA neurons. Fig. (2) shows the distribution of bursting events in time as percent of the total bursting activity.
The significant difference [F(18,189)  6.42, p < 0.0001] of
bursting activity during the baseline period between cocaine

and parthenolide treated groups (75.39% cocaine group vs
13.02% and 20.86% in parthenolide 0.125 mg/kg and 0.250
mg/kg, respectively) indicates that greater part of the cocaine
group’s bursting events occurred before cocaine administration. Thus, acute intravenous cocaine administration completely inhibited bursting activity in dopaminergic VTA neurons. However, animals pre-injected with parthenolide
(0.125 mg/kg or 0.250 mg/kg) maintained a relatively homogenous distribution of bursting activity. This suggests that
parthenolide administration also seems to block cocaine’s
inhibitory effects on bursting activity in VTA DA neurons.
The mean number of spikes per burst analysis showed
that the 0.250 mg/kg parthenolide group demonstrate a
decreased number of spikes after 15 minutes post injection
which recovered around 30 minutes after injection
[F(18,189)  2.41, p < 0002]. The latter effect was not due to
changes in the number of bursting activity as shown in Fig.
(2). On the other hand, the 0.250 mg/kg dose induced a significant decrease in burst duration at 21 and 24 minutes after
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injection [F(18,189)  2.17, p < 0.005] which might account
for the decreased number of spikes observed.
DISCUSSION
The present study demonstrates that parthenolide administration blocks the acute cocaine’s action on VTA DA neuronal firing activity. Similar to the behavioral results published by Pagán et al. 2008, systemic administration of
parthenolide prior to a cocaine injection blocked cocaineinduced firing rate inhibition and bursting activity. Both dosages of parthenolide were effective in blocking cocaine’s
action on putative VTA DA cells. This finding was consistent throughout the experiment.
The neurochemical action of cocaine is to inhibit the reuptake mechanisms of catecholamines causing an increase in
neurotransmitters at the synapse [4]. It has been shown that
acute administration of psychostimulant drugs such as cocaine decrease VTA DA neuronal activity. This action is
likely due to the fact that psychostimulants drugs enhance
extracellular concentrations of dopamine at the somatodendritic area resulting in an activation of impulse-regulating
autoreceptors thus inhibiting neuronal firing [10, 11].
Changes in VTA DA cell activity while the drug of abuse is
onboard are important for triggering the enhancement of
neuronal activity observed after withdrawal from drug exposure. Eventually this increase in VTA neuronal firing is critical in the development of cocaine sensitization [12].
Parthenolide has been shown to play a role in other
mechanisms, such as inhibiting the NF-B cell signaling
pathway [13], suggesting a drug’s interaction with other
mechanisms that might not be in operation at lower dosages.
It is likely that parthenolide at a dose of 0.125 mg/kg is more
effective at exerting its effect on cocaine’s mechanism of
action. Interestingly, neurons treated with parthenolide at
0.250 mg/kg had a reduction in burst duration, which correlated with a diminution in the number of spikes per burst.
Further studies including dose response curves could serve to
clear this issue.
Previous experiments [4] showed that cocaine and
parthenolide do not interact directly; instead, their effect
seems to be localized to a common binding site on the planarian nervous system. Based on this previous study and on
the work presented here, we propose that parthenolide actively competes with cocaine, displacing the drug from inhibiting the transporter and allowing it to function normally.
These observed behavioral and neurophysiological interactions of parthenolide and cocaine are consistent with the idea
of parthenolide acting as a dopamine-sparing, cocaine antagonist (DSCA) [14]. DSCA’s are hypothesized to bind to
the dopamine-cocaine sites on the dopamine transporter in
such a way that block cocaine’s interaction with the transReceived: October 01, 2009

porter, while leaving dopamine interactions with the transporter unaffectaed [10]. Binding studies, could further clarify
parthenolide’s mechanism of action. A positive result could
further clarify parthenolide’s role in the inhibition of
cocaine’s effect.
Since high concentrations of cocaine acutely can be
harmful or even lethal to an organism, a compound that acts
at a common binding site displacing cocaine from it could
have utility as an overdose antidote or therapeutic agent.
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